BioNexus Gene Lab (BGLC) Enterprise Value (2021 - 2026)

BioNexus Gene Lab has disclosed Enterprise Value across 6 years of filings, most recently posting $98994.1 for Q2 2026.

• In Q2 2026, Enterprise Value fell 94.14% year-over-year to $98994.1; the TTM figure through Jun 2026 stood at $98994.1 (down 94.14% YoY), while the FY2025 annual figure was $3.3 million, up 576.22% from the prior year.
• Enterprise Value came in at $98994.1 for Q2 2026 at BioNexus Gene Lab, up from -$1.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $458.9 million in Q2 2023 to a low of -$1.1 million in Q1 2026.
• Average Enterprise Value over 5 years is $79.3 million, with a median of $6.0 million recorded in 2024.
• Year-over-year, Enterprise Value soared 576.22% in 2025 and tumbled 149.73% in 2026.
• Over 5 years, Enterprise Value stood at $162.9 million in 2022, then sank by 97.03% to $4.8 million in 2023, then tumbled by 114.27% to -$691739.7 in 2024, then soared by 576.22% to $3.3 million in 2025, then tumbled by 96.99% to $98994.1 in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $98994.1 in Q2 2026, -$1.1 million in Q1 2026, and $3.3 million in Q4 2025.